Trial site
Dermatology Research Associates
- 16running trials
- 22closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)16 trials
- Psoriasis7 trials
- Alopecia areata4 trials
- Hidradenitis suppurativa4 trials
- Chronic spontaneous urticaria3 trials
- Vitiligo2 trials
- Lupus (SLE)1 trial
- Obesity1 trial
- Phase
- Phase 325 trials
- Phase 27 trials
- Phase 2/35 trials
- Phase 41 trial
- Status
- Completed20 trials
- Active, not recruiting9 trials
- Recruiting5 trials
- Enrolling by invitation2 trials
- Terminated2 trials
- Lead sponsor
- Eli Lilly and Company12 trials
- Incyte Corporation5 trials
- Amgen3 trials
- Boehringer Ingelheim3 trials
- Alumis Inc2 trials
- and 11 more
Running trials
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Active, not recruiting
Recruiting
Enrolling by invitation
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Active, not recruiting
Enrolling by invitation
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alopecia areata2 recruiting
- Atopic dermatitis (eczema)2 recruiting
- Chronic spontaneous urticaria1 recruiting
- Psoriasis1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Completed
A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Completed
Completed
Terminated
Completed
Completed
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis
Terminated
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
Completed
Completed
Completed
Completed
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Site data: ClinicalTrials.govUpdated 15 Nov 2026